ArticleOncotarget2018

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis.

Chiara Citterio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.